Click for best price
Cancer Gene Testing Service Market Size, Share 2024
The global Cancer Gene Testing Service market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Breast Cancer Risk Genetic Testing Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Cancer Gene Testing Service include Natera, Inc., Laboratory Corporation of America Holdings, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated, CooperSurgical, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Twist Bioscience and Sophia Genetics, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Gene Testing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Gene Testing Service. This report contains market size and forecasts of Cancer Gene Testing Service in global, including the following market information:
Global Cancer Gene Testing Service Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Cancer Gene Testing Service companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Gene Testing Service Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Cancer Gene Testing Service Market Segment Percentages, by Type, 2023 (%)
Breast Cancer Risk Genetic Testing
Stomach Cancer Risk Gene Testing
Rectal Cancer Risk Genetic Testing
Others
Global Cancer Gene Testing Service Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Cancer Gene Testing Service Market Segment Percentages, by Application, 2023 (%)
Hospital
Clinic
Global Cancer Gene Testing Service Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Cancer Gene Testing Service Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Gene Testing Service revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Cancer Gene Testing Service revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Natera, Inc.
Laboratory Corporation of America Holdings
F. Hoffmann-La Roche Ltd
Quest Diagnostics Incorporated
CooperSurgical, Inc.
Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc.
Twist Bioscience
Sophia Genetics
Fulgent Genetic, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Gene Testing Service, market overview.
Chapter 2: Global Cancer Gene Testing Service market size in revenue.
Chapter 3: Detailed analysis of Cancer Gene Testing Service company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Gene Testing Service in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cancer Gene Testing Service Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Gene Testing Service Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Gene Testing Service Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Gene Testing Service Overall Market Size
2.1 Global Cancer Gene Testing Service Market Size: 2023 VS 2030
2.2 Global Cancer Gene Testing Service Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Gene Testing Service Players in Global Market
3.2 Top Global Cancer Gene Testing Service Companies Ranked by Revenue
3.3 Global Cancer Gene Testing Service Revenue by Companies
3.4 Top 3 and Top 5 Cancer Gene Testing Service Companies in Global Market, by Revenue in 2023
3.5 Global Companies Cancer Gene Testing Service Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Gene Testing Service Players in Global Market
3.6.1 List of Global Tier 1 Cancer Gene Testing Service Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Gene Testing Service Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Gene Testing Service Market Size Markets, 2023 & 2030
4.1.2 Breast Cancer Risk Genetic Testing
4.1.3 Stomach Cancer Risk Gene Testing
4.1.4 Rectal Cancer Risk Genetic Testing
4.1.5 Others
4.2 By Type - Global Cancer Gene Testing Service Revenue & Forecasts
4.2.1 By Type - Global Cancer Gene Testing Service Revenue, 2019-2024
4.2.2 By Type - Global Cancer Gene Testing Service Revenue, 2025-2030
4.2.3 By Type - Global Cancer Gene Testing Service Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Gene Testing Service Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Cancer Gene Testing Service Revenue & Forecasts
5.2.1 By Application - Global Cancer Gene Testing Service Revenue, 2019-2024
5.2.2 By Application - Global Cancer Gene Testing Service Revenue, 2025-2030
5.2.3 By Application - Global Cancer Gene Testing Service Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Cancer Gene Testing Service Market Size, 2023 & 2030
6.2 By Region - Global Cancer Gene Testing Service Revenue & Forecasts
6.2.1 By Region - Global Cancer Gene Testing Service Revenue, 2019-2024
6.2.2 By Region - Global Cancer Gene Testing Service Revenue, 2025-2030
6.2.3 By Region - Global Cancer Gene Testing Service Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Cancer Gene Testing Service Revenue, 2019-2030
6.3.2 US Cancer Gene Testing Service Market Size, 2019-2030
6.3.3 Canada Cancer Gene Testing Service Market Size, 2019-2030
6.3.4 Mexico Cancer Gene Testing Service Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Cancer Gene Testing Service Revenue, 2019-2030
6.4.2 Germany Cancer Gene Testing Service Market Size, 2019-2030
6.4.3 France Cancer Gene Testing Service Market Size, 2019-2030
6.4.4 U.K. Cancer Gene Testing Service Market Size, 2019-2030
6.4.5 Italy Cancer Gene Testing Service Market Size, 2019-2030
6.4.6 Russia Cancer Gene Testing Service Market Size, 2019-2030
6.4.7 Nordic Countries Cancer Gene Testing Service Market Size, 2019-2030
6.4.8 Benelux Cancer Gene Testing Service Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Cancer Gene Testing Service Revenue, 2019-2030
6.5.2 China Cancer Gene Testing Service Market Size, 2019-2030
6.5.3 Japan Cancer Gene Testing Service Market Size, 2019-2030
6.5.4 South Korea Cancer Gene Testing Service Market Size, 2019-2030
6.5.5 Southeast Asia Cancer Gene Testing Service Market Size, 2019-2030
6.5.6 India Cancer Gene Testing Service Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Cancer Gene Testing Service Revenue, 2019-2030
6.6.2 Brazil Cancer Gene Testing Service Market Size, 2019-2030
6.6.3 Argentina Cancer Gene Testing Service Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Gene Testing Service Revenue, 2019-2030
6.7.2 Turkey Cancer Gene Testing Service Market Size, 2019-2030
6.7.3 Israel Cancer Gene Testing Service Market Size, 2019-2030
6.7.4 Saudi Arabia Cancer Gene Testing Service Market Size, 2019-2030
6.7.5 UAE Cancer Gene Testing Service Market Size, 2019-2030
7 Cancer Gene Testing Service Companies Profiles
7.1 Natera, Inc.
7.1.1 Natera, Inc. Company Summary
7.1.2 Natera, Inc. Business Overview
7.1.3 Natera, Inc. Cancer Gene Testing Service Major Product Offerings
7.1.4 Natera, Inc. Cancer Gene Testing Service Revenue in Global Market (2019-2024)
7.1.5 Natera, Inc. Key News & Latest Developments
7.2 Laboratory Corporation of America Holdings
7.2.1 Laboratory Corporation of America Holdings Company Summary
7.2.2 Laboratory Corporation of America Holdings Business Overview
7.2.3 Laboratory Corporation of America Holdings Cancer Gene Testing Service Major Product Offerings
7.2.4 Laboratory Corporation of America Holdings Cancer Gene Testing Service Revenue in Global Market (2019-2024)
7.2.5 Laboratory Corporation of America Holdings Key News & Latest Developments
7.3 F. Hoffmann-La Roche Ltd
7.3.1 F. Hoffmann-La Roche Ltd Company Summary
7.3.2 F. Hoffmann-La Roche Ltd Business Overview
7.3.3 F. Hoffmann-La Roche Ltd Cancer Gene Testing Service Major Product Offerings
7.3.4 F. Hoffmann-La Roche Ltd Cancer Gene Testing Service Revenue in Global Market (2019-2024)
7.3.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.4 Quest Diagnostics Incorporated
7.4.1 Quest Diagnostics Incorporated Company Summary
7.4.2 Quest Diagnostics Incorporated Business Overview
7.4.3 Quest Diagnostics Incorporated Cancer Gene Testing Service Major Product Offerings
7.4.4 Quest Diagnostics Incorporated Cancer Gene Testing Service Revenue in Global Market (2019-2024)
7.4.5 Quest Diagnostics Incorporated Key News & Latest Developments
7.5 CooperSurgical, Inc.
7.5.1 CooperSurgical, Inc. Company Summary
7.5.2 CooperSurgical, Inc. Business Overview
7.5.3 CooperSurgical, Inc. Cancer Gene Testing Service Major Product Offerings
7.5.4 CooperSurgical, Inc. Cancer Gene Testing Service Revenue in Global Market (2019-2024)
7.5.5 CooperSurgical, Inc. Key News & Latest Developments
7.6 Agilent Technologies, Inc.
7.6.1 Agilent Technologies, Inc. Company Summary
7.6.2 Agilent Technologies, Inc. Business Overview
7.6.3 Agilent Technologies, Inc. Cancer Gene Testing Service Major Product Offerings
7.6.4 Agilent Technologies, Inc. Cancer Gene Testing Service Revenue in Global Market (2019-2024)
7.6.5 Agilent Technologies, Inc. Key News & Latest Developments
7.7 Thermo Fisher Scientific, Inc.
7.7.1 Thermo Fisher Scientific, Inc. Company Summary
7.7.2 Thermo Fisher Scientific, Inc. Business Overview
7.7.3 Thermo Fisher Scientific, Inc. Cancer Gene Testing Service Major Product Offerings
7.7.4 Thermo Fisher Scientific, Inc. Cancer Gene Testing Service Revenue in Global Market (2019-2024)
7.7.5 Thermo Fisher Scientific, Inc. Key News & Latest Developments
7.8 Twist Bioscience
7.8.1 Twist Bioscience Company Summary
7.8.2 Twist Bioscience Business Overview
7.8.3 Twist Bioscience Cancer Gene Testing Service Major Product Offerings
7.8.4 Twist Bioscience Cancer Gene Testing Service Revenue in Global Market (2019-2024)
7.8.5 Twist Bioscience Key News & Latest Developments
7.9 Sophia Genetics
7.9.1 Sophia Genetics Company Summary
7.9.2 Sophia Genetics Business Overview
7.9.3 Sophia Genetics Cancer Gene Testing Service Major Product Offerings
7.9.4 Sophia Genetics Cancer Gene Testing Service Revenue in Global Market (2019-2024)
7.9.5 Sophia Genetics Key News & Latest Developments
7.10 Fulgent Genetic, Inc.
7.10.1 Fulgent Genetic, Inc. Company Summary
7.10.2 Fulgent Genetic, Inc. Business Overview
7.10.3 Fulgent Genetic, Inc. Cancer Gene Testing Service Major Product Offerings
7.10.4 Fulgent Genetic, Inc. Cancer Gene Testing Service Revenue in Global Market (2019-2024)
7.10.5 Fulgent Genetic, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Gene Testing Service Market Opportunities & Trends in Global Market
Table 2. Cancer Gene Testing Service Market Drivers in Global Market
Table 3. Cancer Gene Testing Service Market Restraints in Global Market
Table 4. Key Players of Cancer Gene Testing Service in Global Market
Table 5. Top Cancer Gene Testing Service Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Cancer Gene Testing Service Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Cancer Gene Testing Service Revenue Share by Companies, 2019-2024
Table 8. Global Companies Cancer Gene Testing Service Product Type
Table 9. List of Global Tier 1 Cancer Gene Testing Service Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Gene Testing Service Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Cancer Gene Testing Service Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Cancer Gene Testing Service Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Cancer Gene Testing Service Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Cancer Gene Testing Service Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Cancer Gene Testing Service Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Cancer Gene Testing Service Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Cancer Gene Testing Service Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Cancer Gene Testing Service Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Cancer Gene Testing Service Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Cancer Gene Testing Service Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Cancer Gene Testing Service Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Cancer Gene Testing Service Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Cancer Gene Testing Service Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Cancer Gene Testing Service Revenue, (US$, Mn), 2025-2030
Table 30. Natera, Inc. Company Summary
Table 31. Natera, Inc. Cancer Gene Testing Service Product Offerings
Table 32. Natera, Inc. Cancer Gene Testing Service Revenue (US$, Mn) & (2019-2024)
Table 33. Natera, Inc. Key News & Latest Developments
Table 34. Laboratory Corporation of America Holdings Company Summary
Table 35. Laboratory Corporation of America Holdings Cancer Gene Testing Service Product Offerings
Table 36. Laboratory Corporation of America Holdings Cancer Gene Testing Service Revenue (US$, Mn) & (2019-2024)
Table 37. Laboratory Corporation of America Holdings Key News & Latest Developments
Table 38. F. Hoffmann-La Roche Ltd Company Summary
Table 39. F. Hoffmann-La Roche Ltd Cancer Gene Testing Service Product Offerings
Table 40. F. Hoffmann-La Roche Ltd Cancer Gene Testing Service Revenue (US$, Mn) & (2019-2024)
Table 41. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 42. Quest Diagnostics Incorporated Company Summary
Table 43. Quest Diagnostics Incorporated Cancer Gene Testing Service Product Offerings
Table 44. Quest Diagnostics Incorporated Cancer Gene Testing Service Revenue (US$, Mn) & (2019-2024)
Table 45. Quest Diagnostics Incorporated Key News & Latest Developments
Table 46. CooperSurgical, Inc. Company Summary
Table 47. CooperSurgical, Inc. Cancer Gene Testing Service Product Offerings
Table 48. CooperSurgical, Inc. Cancer Gene Testing Service Revenue (US$, Mn) & (2019-2024)
Table 49. CooperSurgical, Inc. Key News & Latest Developments
Table 50. Agilent Technologies, Inc. Company Summary
Table 51. Agilent Technologies, Inc. Cancer Gene Testing Service Product Offerings
Table 52. Agilent Technologies, Inc. Cancer Gene Testing Service Revenue (US$, Mn) & (2019-2024)
Table 53. Agilent Technologies, Inc. Key News & Latest Developments
Table 54. Thermo Fisher Scientific, Inc. Company Summary
Table 55. Thermo Fisher Scientific, Inc. Cancer Gene Testing Service Product Offerings
Table 56. Thermo Fisher Scientific, Inc. Cancer Gene Testing Service Revenue (US$, Mn) & (2019-2024)
Table 57. Thermo Fisher Scientific, Inc. Key News & Latest Developments
Table 58. Twist Bioscience Company Summary
Table 59. Twist Bioscience Cancer Gene Testing Service Product Offerings
Table 60. Twist Bioscience Cancer Gene Testing Service Revenue (US$, Mn) & (2019-2024)
Table 61. Twist Bioscience Key News & Latest Developments
Table 62. Sophia Genetics Company Summary
Table 63. Sophia Genetics Cancer Gene Testing Service Product Offerings
Table 64. Sophia Genetics Cancer Gene Testing Service Revenue (US$, Mn) & (2019-2024)
Table 65. Sophia Genetics Key News & Latest Developments
Table 66. Fulgent Genetic, Inc. Company Summary
Table 67. Fulgent Genetic, Inc. Cancer Gene Testing Service Product Offerings
Table 68. Fulgent Genetic, Inc. Cancer Gene Testing Service Revenue (US$, Mn) & (2019-2024)
Table 69. Fulgent Genetic, Inc. Key News & Latest Developments
List of Figures
Figure 1. Cancer Gene Testing Service Segment by Type in 2023
Figure 2. Cancer Gene Testing Service Segment by Application in 2023
Figure 3. Global Cancer Gene Testing Service Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Cancer Gene Testing Service Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Cancer Gene Testing Service Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Gene Testing Service Revenue in 2023
Figure 8. By Type - Global Cancer Gene Testing Service Revenue Market Share, 2019-2030
Figure 9. By Application - Global Cancer Gene Testing Service Revenue Market Share, 2019-2030
Figure 10. By Type - Global Cancer Gene Testing Service Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Cancer Gene Testing Service Revenue Market Share, 2019-2030
Figure 12. By Application - Global Cancer Gene Testing Service Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Cancer Gene Testing Service Revenue Market Share, 2019-2030
Figure 14. By Region - Global Cancer Gene Testing Service Revenue Market Share, 2019-2030
Figure 15. By Country - North America Cancer Gene Testing Service Revenue Market Share, 2019-2030
Figure 16. US Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Cancer Gene Testing Service Revenue Market Share, 2019-2030
Figure 20. Germany Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2030
Figure 21. France Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Cancer Gene Testing Service Revenue Market Share, 2019-2030
Figure 28. China Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2030
Figure 32. India Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Cancer Gene Testing Service Revenue Market Share, 2019-2030
Figure 34. Brazil Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Cancer Gene Testing Service Revenue Market Share, 2019-2030
Figure 37. Turkey Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Cancer Gene Testing Service Revenue, (US$, Mn), 2019-2030
Figure 41. Natera, Inc. Cancer Gene Testing Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Laboratory Corporation of America Holdings Cancer Gene Testing Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. F. Hoffmann-La Roche Ltd Cancer Gene Testing Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Quest Diagnostics Incorporated Cancer Gene Testing Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. CooperSurgical, Inc. Cancer Gene Testing Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Agilent Technologies, Inc. Cancer Gene Testing Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Thermo Fisher Scientific, Inc. Cancer Gene Testing Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Twist Bioscience Cancer Gene Testing Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Sophia Genetics Cancer Gene Testing Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Fulgent Genetic, Inc. Cancer Gene Testing Service Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
